Bristol-Myers Squibb Mergers and Acquisitions Summary

Life Science Company

Bristol-Myers Squibb has acquired 20 companies, including 6 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 12 assets.

Bristol-Myers Squibb’s largest acquisition to date was in 2019, when it acquired Celgene for $74.0B. It’s largest disclosed sale occurred in 2001, when it sold Clairol to The Procter & Gamble for $5.0B. Bristol-Myers Squibb has acquired in 8 different US states, and 4 countries. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Bristol-Myers Squibb’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity31
    • M&A Buy Activity19
    • M&A Sell Activity12
  • Total Sectors Invested 1
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 14
  • M&A Advisors 10

Bristol-Myers Squibb Co. (Bristol-Myers Squibb)

430 East 29th Street 14th Floor,
New York, New York 10016
United States,
(212) 546-4000
www.bms.com

Bristol-Myers Squibb is a life science company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. The Company's pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from biological processes. The majority of Bristol-Myers Squibb's revenue comes from products in the following therapeutic classes: cardiovascular; virology, including human immunodeficiency virus (HIV) infection; oncology; neuroscience; immunoscience; and metabolics. Bristol-Myers Squibb was originally established in 1887 and is based in New York City.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.8/yr) # 15 1 - 1 2 - 19
vol $22.6B $74.0B $13.1B $109.7B
Sell (0.8/yr) # 8 1 1 1 1 - 12
vol $12.5B $525M $13.0B
  31

Most Recent M&A

Company Date Value Type
Galecto, Inc. 2020-10-28 - IPO
Copenhagen, Denmark · www.galecto.com
MyoKardia, Inc. 2020-10-05 13.1B USD Add-on Acquisition
South San Francisco, California · www.myokardia.com
Formation Biologics, Inc. 2020-08-24 - Add-on Acquisition
Austin, Texas · www.forbius.com
Bristol-Myers Squibb Co. - Anagni Manufacturing Facility 2019-06-19 - Divestiture
Anagni, Italy
Celgene Corp. 2019-01-03 74.0B USD Add-on Acquisition
Summit, New Jersey · www.celgene.com
Upsa 2018-10-08 - Divestiture
, France
Lantheus Medical Imaging, Inc. 2017-12-17 525M USD Divestiture
North Billerica, Massachusetts · www.lantheus.com
IFM Therapeutics 2017-08-03 - Add-on Acquisition
Boston, Massachusetts · www.ifmthera.com
Cormorant Pharmaceuticals AB 2016-07-05 95M USD Add-on Acquisition
, Sweden
Padlock Therapeutics, Inc. 2016-03-23 225M USD Add-on Acquisition
Cambridge, Massachusetts
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Celgene Corp. 2019-01-03 Otezla 2019-08-26 1
Summit, New Jersey · www.celgene.com , United States
IFM Therapeutics 2017-08-03 IFM Tre 2019-04-01 1
Boston, Massachusetts · www.ifmthera.com Boston, Massachusetts

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 19 (100%) 109.7B (100%) 4 (33%) 3.1B (23%)
Medical Products - - 5 (42%) 5.0B (38%)
Consumer Products - - 2 (17%) 5.0B (38%)
Food - - 1 (8%) -
Total 19 $109.7B 12 $13.0B

By Geo

State/Country Buy Value Sell Value
United States 16 109.1B 9 13.0B
  California 6 20.9B - -
  Massachusetts 3 655M 1 525M
  New Jersey 2 76.1B 1 4.1B
  Washington 1 885M - -
  Texas 1 - - -
  North Carolina 1 300M - -
  Georgia 1 2.5B - -
  Delaware 1 7.8B - -
  Ohio - - 1 -
  Indiana - - 1 -
  Illinois - - 1 -
  Florida - - 1 370M
  Connecticut - - 1 5.0B
Denmark 1 - 1 -
France - - 1 -
Italy - - 1 -
Sweden 1 95M - -
United Kingdom 1 475M - -
Domestic 16 (84%) 109.1B (99%) 9 (75%) 13.0B (100%)
Cross-border 3 (16%) 570M (1%) 3 (25%) -
Total 19 $109.7B 12 $13.0B

Top M&A Advisors

Financial Deals
Morgan Stanley
4
Citigroup Investment Banking
3
Evercore Group LLC
2
Legal Deals
Kirkland & Ellis LLP
6
Cravath, Swaine & Moore LLP
4
Covington & Burling LLP
1

Deal Values

buy # Total
> $1B 7 $106.1B
$100M to $1B 7 $3.5B
< $100M 1 $95M
TOTAL $109.7B
Largest Celgene Corp.
$74.0B (2019-01-03)
sell # Total
> $1B 3 $11.8B
$100M to $1B 3 $1.2B
TOTAL $13.0B
Largest Clairol, Inc.
$5.0B (2001-05-22)

M&A Connections

Deals
Acquired from
Investor(s)
5%
1 (5%)
Strategic(s)
5%
1 (5%)
Divested to
Investor(s)
8%
1 (8%)
Strategic(s)
58%
7 (58%)

 Subscribe to unlock this and 165,606
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 154K M&A Transactions
  • 161K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 51K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.